Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Spobio Research Center is the research and development division of LiveSpo Pharma, a Vietnamese biotechnology company specializing in spore-based probiotics. The center developed the proprietary LiveSpo Spore Technology, which produces multi-strain, high-concentration probiotic spores in a stable liquid format that is resistant to heat and gastric acid. Their commercial portfolio includes products targeting digestive health, respiratory infections, and dermatological conditions, aiming to provide effective alternatives to traditional antibiotics. Led by Dr. Nguyen Hoa Anh, the center conducts clinical research to validate the efficacy of Bacillus spores in restoring microbiome balance. Spobio's innovations are exported globally, supported by international certifications and clinical evidence.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Spobio Research Center.